Si-Bone Inc - Asset Resilience Ratio
Si-Bone Inc (SIBN) has an Asset Resilience Ratio of 50.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Si-Bone Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2024)
This chart shows how Si-Bone Inc's Asset Resilience Ratio has changed over time. See Si-Bone Inc net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Si-Bone Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Si-Bone Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $119.26 Million | 50.91% |
| Total Liquid Assets | $119.26 Million | 50.91% |
Asset Resilience Insights
- Very High Liquidity: Si-Bone Inc maintains exceptional liquid asset reserves at 50.91% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Si-Bone Inc Industry Peers by Asset Resilience Ratio
Compare Si-Bone Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Si-Bone Inc (2018–2024)
The table below shows the annual Asset Resilience Ratio data for Si-Bone Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 49.95% | $115.09 Million | $230.44 Million | -7.66pp |
| 2023-12-31 | 57.61% | $132.75 Million | $230.43 Million | +9.01pp |
| 2022-12-31 | 48.60% | $76.57 Million | $157.55 Million | +4.74pp |
| 2021-12-31 | 43.86% | $83.56 Million | $190.51 Million | -20.16pp |
| 2020-12-31 | 64.02% | $142.85 Million | $223.14 Million | -5.50pp |
| 2019-12-31 | 69.52% | $81.34 Million | $117.01 Million | -0.58pp |
| 2018-12-31 | 70.10% | $97.10 Million | $138.52 Million | -- |
About Si-Bone Inc
SI-BONE, Inc., a medical device company, focuses on solving musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company offers proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and degeneration, adult deformity and degeneration, and pelvic trauma, as well as implantable bone products. It also provides iFu… Read more